Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Messemaker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|February 18, 2021
Tumor-infiltrating dendritic cell states are conserved across solid human cancersGenevieve M Gerhard, Ruben Bill, Marius Messemaker, et al.
Cell Reports|September 23, 2020
Tumor-Promoting Ly-6G<sup>+</sup> SiglecF<sup>high</sup> Cells Are Mature and Long-Lived NeutrophilsChristina Pfirschke, Camilla Engblom, Jeremy Gungabeesoon, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A functionally validated TCR-pMHC database for TCR specificity model developmentMarius Messemaker, Bjørn P Y Kwee, Živa Moravec, et al.
Cell|August 3, 2021
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironmentMauro Di Pilato, Raphael Kfuri-Rubens, Jasper N Pruessmann, et al.
Cancer Immunology Research|November 19, 2021
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic CellsChristina Pfirschke, Rapolas Zilionis, Camilla Engblom, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|February 18, 2021
Tumor-infiltrating dendritic cell states are conserved across solid human cancersGenevieve M Gerhard, Ruben Bill, Marius Messemaker, et al.
Cell Reports|September 23, 2020
Tumor-Promoting Ly-6G<sup>+</sup> SiglecF<sup>high</sup> Cells Are Mature and Long-Lived NeutrophilsChristina Pfirschke, Camilla Engblom, Jeremy Gungabeesoon, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A functionally validated TCR-pMHC database for TCR specificity model developmentMarius Messemaker, Bjørn P Y Kwee, Živa Moravec, et al.
Cell|August 3, 2021
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironmentMauro Di Pilato, Raphael Kfuri-Rubens, Jasper N Pruessmann, et al.
Cancer Immunology Research|November 19, 2021
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic CellsChristina Pfirschke, Rapolas Zilionis, Camilla Engblom, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Pageof 1